Activase 50 MG vials
Ended Awarded
- Contract number
- SPE2DX25F1SRS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $0
Award facts
- Contract value 0% obligated
-
- $0.00 Current, with exercised options
- $5,729.42 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order (4566359301) awards AmerisourceBergen Drug Corp $5,729.42 to supply 50 milligram vials of Activase, a thrombolytic medication used to dissolve blood clots in acute medical emergencies. The contract was awarded on November 7, 2024, with an ultimate completion date of November 8, 2024, and represents a firm fixed-price delivery order with no set-aside designation. The award is funded by the Medical Supply Chain division of the Defense Logistics Agency and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies and medications to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company maintains an extensive portfolio of federal contract awards for brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains. All reviewed contract awards demonstrate competitively awarded delivery orders with firm fixed pricing, reflecting the company's capability to meet federal procurement requirements through open competition. This specific award for Activase vials reflects the company's ongoing role as a key vendor supporting military and veteran healthcare supply needs.
Quick answers
Who was awarded contract SPE2DX25F1SRS?
SPE2DX25F1SRS was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on November 7, 2024.
How much is contract SPE2DX25F1SRS worth?
The government has obligated $0 on SPE2DX25F1SRS. Its potential value, with all options, is $5,729.
Is contract SPE2DX25F1SRS an order under another contract?
Yes. SPE2DX25F1SRS is a delivery order under SPE2DX15D7056, an indefinite delivery contract.
Was contract SPE2DX25F1SRS competed?
The extent of competition for SPE2DX25F1SRS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award